Medline Inc. (MDLN) SEC filings

MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 2/3066% above fair value

$39.47−0.51 (-1.28%)

Close on Nov 13, 2026Market cap $51.89BP/E –Yield –

SEC filings

15 of Medline's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Quarterly report	10-Q	Sep 26, 2026	Nov 4, 2026	SEC EDGAR
Current report	8-K	Nov 4, 2026	Nov 4, 2026	SEC EDGAR
Current report	8-K	Oct 21, 2026	Oct 21, 2026	SEC EDGAR
Current report	8-K	Oct 13, 2026	Oct 15, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 27, 2026	Aug 5, 2026	SEC EDGAR
Current report	8-K	Aug 5, 2026	Aug 5, 2026	SEC EDGAR
Current report	8-K	Jul 7, 2026	Jul 9, 2026	SEC EDGAR
Current report	8-K	Jun 11, 2026	Jun 12, 2026	SEC EDGAR
Current report	8-K	May 28, 2026	Jun 2, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 28, 2026	May 6, 2026	SEC EDGAR
Current report	8-K	May 6, 2026	May 6, 2026	SEC EDGAR
Proxy statement	DEF 14A	Jun 11, 2026	Apr 23, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Feb 25, 2026	SEC EDGAR
Current report	8-K	Feb 25, 2026	Feb 25, 2026	SEC EDGAR
Current report	8-K	Dec 16, 2025	Dec 22, 2025	SEC EDGAR

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is MDLN.

Gross margin25.7% · median 54.8%

Operating margin5.7% · median 10.7%

Net margin3.8% · median 3.0%

Advertisement
300 × 250

See a number that looks wrong?